Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume 44, Issue 3, Pages 276-284
Publisher
Wiley
Online
2013-12-19
DOI
10.1111/eci.12230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
- (2013) Suetonia C. Palmer et al. ANNALS OF INTERNAL MEDICINE
- Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand
- (2012) Ksenija Stach et al. Cardiology Journal
- Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy
- (2012) Hala O. El Mesallamy et al. CLINICAL BIOCHEMISTRY
- Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy
- (2012) S.M. Titan et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial
- (2012) T. Almquist et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Recent Advances on the Role of Cytokines in Atherosclerosis
- (2011) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy
- (2011) Masanori Abe et al. Journal of Atherosclerosis and Thrombosis
- The Effect of Ezetimibe and Simvastatin on Monocyte Cytokine Release in Patients With Isolated Hypercholesterolemia
- (2011) Robert Krysiak et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
- (2010) Ahmed A. Elmarakby et al. Cardiovascular Therapeutics
- Pleiotropic effects of ezetimibe: Do they really exist?
- (2010) Michalis Kalogirou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect
- (2009) D Gómez-Garre et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adaptive immunity and atherosclerosis
- (2009) John Andersson et al. CLINICAL IMMUNOLOGY
- Executive Summary: Standards of Medical Care in Diabetes--2010
- (2009) DIABETES CARE
- A catalogue of reporting guidelines for health research
- (2009) I. Simera et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Interferon gamma: A master regulator of atherosclerosis
- (2008) James E. McLaren et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Ezetimibe, a Selective Inhibitor of the Transport of Cholesterol
- (2008) Shin-ichiro Miura et al. INTERNAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search